PRMT5
Protein arginine N-methyltransferase 5
Also known as: ANM5_HUMAN, HRMT1L5, SKB1, SKB1Hs
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O14744
- Gene
- PRMT5
- Ensembl
- ENSG00000100462
- Chromosome
- 14
- Canonical length
- 637 aa
- Protein class
- Enzymes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
This gene encodes an enzyme that belongs to the methyltransferase family. The encoded protein catalyzes the transfer of methyl groups to the amino acid arginine, in target proteins that include histones, transcriptional elongation factors and the tumor suppressor p53. This gene plays a role in several cellular processes, including transcriptional regulation, and the assembly of small nuclear ribonucleoproteins. A pseudogene of this gene has been defined on chromosome 4. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Sep 2015]
Canonical amino-acid sequenceUniProt
637 residues, UniProt reviewed canonical sequence.
>O14744|PRMT5
1 MAAMAVGGAG GSRVSSGRDL NCVPEIADTL GAVAKQGFDF LCMPVFHPRF KREFIQEPAK
61 NRPGPQTRSD LLLSGRDWNT LIVGKLSPWI RPDSKVEKIR RNSEAAMLQE LNFGAYLGLP
121 AFLLPLNQED NTNLARVLTN HIHTGHHSSM FWMRVPLVAP EDLRDDIIEN APTTHTEEYS
181 GEEKTWMWWH NFRTLCDYSK RIAVALEIGA DLPSNHVIDR WLGEPIKAAI LPTSIFLTNK
241 KGFPVLSKMH QRLIFRLLKL EVQFIITGTN HHSEKEFCSY LQYLEYLSQN RPPPNAYELF
301 AKGYEDYLQS PLQPLMDNLE SQTYEVFEKD PIKYSQYQQA IYKCLLDRVP EEEKDTNVQV
361 LMVLGAGRGP LVNASLRAAK QADRRIKLYA VEKNPNAVVT LENWQFEEWG SQVTVVSSDM
421 REWVAPEKAD IIVSELLGSF ADNELSPECL DGAQHFLKDD GVSIPGEYTS FLAPISSSKL
481 YNEVRACREK DRDPEAQFEM PYVVRLHNFH QLSAPQPCFT FSHPNRDPMI DNNRYCTLEF
541 PVEVNTVLHG FAGYFETVLY QDITLSIRPE THSPGMFSWF PILFPIKQPI TVREGQTICV
601 RFWRCSNSKK VWYEWAVTAP VCSAIHNPTG RSYTIGLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PRMT5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 66 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 66 nTPM
- esophagus: 48 nTPM
- parathyroid gland: 44 nTPM
- ovary: 43 nTPM
- fallopian tube: 42 nTPM
- tongue: 39 nTPM
Single-cell type
- oocytes: 115 nCPM
- esophageal apical cells: 103 nCPM
- differentiating spermatogonia: 68 nCPM
- early primary spermatocytes: 57 nCPM
- cytotrophoblasts: 52 nCPM
- migrating cytotrophoblasts: 52 nCPM
Immune cell
- myeloid DC: 43 nTPM
- intermediate monocyte: 32 nTPM
- classical monocyte: 31 nTPM
- memory B-cell: 31 nTPM
- total PBMC: 29 nTPM
- naive B-cell: 28 nTPM
Brain region
- choroid plexus: 37 nTPM
- midbrain: 32 nTPM
- white matter: 32 nTPM
- pons: 32 nTPM
- hypothalamus: 31 nTPM
- thalamus: 31 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PRMT5.
Disease | ImmuneIEDB
Conditions an epitope on PRMT5 was assayed in.
- narcolepsy B cell
- multiple sclerosis B cell
- peripheral nervous system disease B cell
ReferencesPubMed · IEDB
Publications for PRMT5 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Identification and validation of anti-protein arginine methyltransferase 5 (PRMT5) antibody as a novel biomarker for systemic sclerosis (SSc).
2024 · Ann Rheum Dis · RCR 2.3 · 11 citations - Anti-protein arginine methyltransferase 5 (PRMT5) antibodies is associated with interstitial lung disease in rheumatoid arthritis.
2025 · Sci Rep · 1 citations
Reference: B cellIEDB
1 publication
- Whole-Proteome Peptide Microarrays for Profiling Autoantibody Repertoires within Multiple Sclerosis and Narcolepsy.
2017 · J Proteome Res · RCR 2.2 · 57 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.12
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.03
- DepMap mean gene effect
- -1
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- chromatin remodeling
- circadian regulation of gene expression
- DNA-templated transcription termination
- endothelial cell activation
- Golgi ribbon formation
- liver regeneration
- negative regulation of cell differentiation
- negative regulation of gene expression via chromosomal CpG island methylation
- peptidyl-arginine methylation
- positive regulation of mRNA splicing, via spliceosome
- positive regulation of oligodendrocyte differentiation
- regulation of DNA-templated transcription
- regulation of ERK1 and ERK2 cascade
- regulation of mitotic nuclear division
- regulation of signal transduction by p53 class mediator
- spliceosomal snRNP assembly
- peptidyl-arginine N-methylation
- positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway
Molecular functions
- E-box binding
- histone H3 methyltransferase activity
- histone H4R3 methyltransferase activity
- histone methyltransferase activity
- identical protein binding
- methyl-CpG binding
- methyltransferase activity
- p53 binding
- protein heterodimerization activity
- protein-arginine N-methyltransferase activity
- protein-arginine omega-N symmetric methyltransferase activity
- ribonucleoprotein complex binding
- transcription corepressor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein arginine N-methyltransferase
- S-adenosyl-L-methionine-dependent methyltransferase superfamily
- Protein arginine N-methyltransferase PRMT5
- PRMT5 arginine-N-methyltransferase
- PRMT5, TIM barrel domain
- PRMT5, oligomerisation domain
- PRMT5 arginine-N-methyltransferase
- PRMT5 TIM barrel domain
- PRMT5 oligomerisation domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PRMT5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PRMT5 as an antibody target. Whether an autoantibody or antibody against PRMT5 could matter depends on whether native PRMT5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PRMT5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PRMT5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...